Healthpeak Properties, Inc. (NYSE:DOC) Director Buys $99,768.79 in Stock

Healthpeak Properties, Inc. (NYSE:DOC - Get Free Report) Director Tommy G. Thompson bought 5,777 shares of the company's stock in a transaction dated Wednesday, May 28th. The shares were purchased at an average cost of $17.27 per share, with a total value of $99,768.79. Following the acquisition, the director now directly owns 144,290 shares of the company's stock, valued at approximately $2,491,888.30. This represents a 4.17% increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Healthpeak Properties Price Performance

DOC stock traded up $0.03 during mid-day trading on Wednesday, hitting $17.38. 3,840,865 shares of the stock were exchanged, compared to its average volume of 5,082,324. The stock has a market capitalization of $12.07 billion, a price-to-earnings ratio of 49.62, a PEG ratio of 2.17 and a beta of 1.05. Healthpeak Properties, Inc. has a 12 month low of $16.64 and a 12 month high of $23.26. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.35 and a quick ratio of 1.35. The business has a fifty day moving average price of $18.33 and a 200 day moving average price of $19.80.

Healthpeak Properties (NYSE:DOC - Get Free Report) last announced its earnings results on Thursday, April 24th. The real estate investment trust reported $0.46 earnings per share for the quarter, meeting analysts' consensus estimates of $0.46. Healthpeak Properties had a net margin of 9.00% and a return on equity of 2.61%. The firm had revenue of $702.89 million for the quarter, compared to analyst estimates of $690.76 million. During the same quarter in the previous year, the firm posted $0.45 EPS. The company's revenue for the quarter was up 15.9% compared to the same quarter last year. On average, sell-side analysts anticipate that Healthpeak Properties, Inc. will post 1.86 EPS for the current year.

Healthpeak Properties Announces Dividend

The business also recently declared a dividend, which will be paid on Friday, May 30th. Stockholders of record on Tuesday, May 20th will be issued a dividend of $0.1017 per share. This represents a dividend yield of 7.05%. The ex-dividend date of this dividend is Monday, May 19th. Healthpeak Properties's payout ratio is presently 305.00%.

Institutional Trading of Healthpeak Properties

A number of hedge funds have recently bought and sold shares of DOC. TCTC Holdings LLC increased its stake in shares of Healthpeak Properties by 124.3% in the first quarter. TCTC Holdings LLC now owns 1,355 shares of the real estate investment trust's stock worth $27,000 after purchasing an additional 751 shares in the last quarter. Brooklyn Investment Group increased its stake in Healthpeak Properties by 198.9% in the 1st quarter. Brooklyn Investment Group now owns 1,312 shares of the real estate investment trust's stock worth $27,000 after buying an additional 873 shares during the period. Mizuho Bank Ltd. bought a new stake in Healthpeak Properties during the 4th quarter valued at $28,000. Harvest Fund Management Co. Ltd purchased a new position in Healthpeak Properties during the 4th quarter valued at about $30,000. Finally, Future Financial Wealth Managment LLC purchased a new stake in Healthpeak Properties during the first quarter worth $30,000. Hedge funds and other institutional investors own 93.57% of the company's stock.

Wall Street Analyst Weigh In

DOC has been the subject of a number of analyst reports. Evercore ISI dropped their price target on shares of Healthpeak Properties from $23.00 to $21.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Wall Street Zen lowered Healthpeak Properties from a "hold" rating to a "sell" rating in a research note on Thursday, May 1st. Wedbush cut their target price on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating for the company in a research report on Monday, April 28th. Robert W. Baird decreased their price target on Healthpeak Properties from $24.00 to $22.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 29th. Finally, Argus reaffirmed a "buy" rating and set a $25.00 price objective on shares of Healthpeak Properties in a research report on Tuesday, April 29th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and nine have issued a buy rating to the company's stock. According to MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $23.45.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.